Home › NDC Lookup › RxCUI directory › RxCUI 854988

Perindopril erbumine 4 MG Oral Tablet — RxCUI 854988

RxNorm drug concept · Semantic clinical drug
RxCUI 854988 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI854988
Official namePerindopril erbumine 4 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,251 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Perindopril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Perindopril is mainly used for two things: lowering high blood pressure and — if you have stable coronary artery disease — reducing your chances of a heart attack or dying from a h...
  • Yes, a dry, persistent cough is the most common side effect with perindopril — it happened in about 12% of patients in clinical trials, compared to about 4.5% with placebo. It's no...
  • I've heard ACE inhibitors cause a cough. Is that really common?
  • No — this is one of the most important warnings with perindopril. This drug can cause serious kidney damage and even death in an unborn baby, particularly in the second and third t...
📖 Read our full Perindopril guide →

🕸️ Concept Web — How Perindopril erbumine 4 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Perindopril erbumine 4 MG Oral Tablet RxCUI 854988

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Perindopril 54552
    • Perindopril erbumine 72260
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Aceon 261438
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Perindopril Oral Tablet 373293
    • Perindopril erbumine Oral Tablet 2646724
    • Perindopril Oral Product 1165430
    • Perindopril Pill 1165431
    • Perindopril erbumine Oral Product 2660032
    • Perindopril erbumine Pill 2659540
    • Perindopril Oral Tablet [Aceon] 368233
    • Perindopril erbumine Oral Tablet [Aceon] 2656718
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Perindopril erbumine 4 MG 854987
    • Perindopril erbumine 4 MG Oral Tablet [Aceon] 854990
    • Perindopril erbumine 4 MG [Aceon] 854989

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Perindopril erbumine 4 MG SCDC · 854987
  • Perindopril Oral Tablet SCDF · 373293
  • Perindopril erbumine Oral Tablet SCDFP · 2646724
  • Perindopril Oral Product SCDG · 1165430
  • Perindopril Pill SCDG · 1165431
  • Perindopril erbumine Oral Product SCDGP · 2660032
  • Perindopril erbumine Pill SCDGP · 2659540

Brand-Name Concepts

  • Perindopril erbumine 4 MG Oral Tablet [Aceon] SBD · 854990
  • Perindopril erbumine 4 MG [Aceon] SBDC · 854989
  • Perindopril Oral Tablet [Aceon] SBDF · 368233
  • Perindopril erbumine Oral Tablet [Aceon] SBDFP · 2656718
  • Aceon Oral Product SBDG · 1168400
  • Aceon Pill SBDG · 1168401
  • Aceon BN · 261438

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 854988 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65862-0286-01 100 TABLET in 1 BOTTLE (65862-286-01) Perindopril Erbumine Aurobindo Pharma Limited 2009-11-10
65862-0287-01 100 TABLET in 1 BOTTLE (65862-287-01) Perindopril Erbumine Aurobindo Pharma Limited 2009-11-10
65862-0288-01 100 TABLET in 1 BOTTLE (65862-288-01) Perindopril Erbumine Aurobindo Pharma Limited 2009-11-10
Observed labelers: Aurobindo Pharma Limited (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.